BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 35611897)

  • 1. [Biomarkers of amyotrophic lateral sclerosis].
    Khabibrakhmanov AN; Mukhamedyarov MA; Bogdanov EI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(5):30-35. PubMed ID: 35611897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluid biomarkers for amyotrophic lateral sclerosis: a review.
    Irwin KE; Sheth U; Wong PC; Gendron TF
    Mol Neurodegener; 2024 Jan; 19(1):9. PubMed ID: 38267984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biofluid Biomarkers in the Prognosis of Amyotrophic Lateral Sclerosis: Recent Developments and Therapeutic Applications.
    Sanchez-Tejerina D; Llaurado A; Sotoca J; Lopez-Diego V; Vidal Taboada JM; Salvado M; Juntas-Morales R
    Cells; 2023 Apr; 12(8):. PubMed ID: 37190090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA as a source of biomarkers for amyotrophic lateral sclerosis.
    Kiaei L; Kiaei M
    Metab Brain Dis; 2022 Aug; 37(6):1697-1702. PubMed ID: 33905071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarkers for amyotrophic lateral sclerosis.
    Witzel S; Mayer K; Oeckl P
    Curr Opin Neurol; 2022 Oct; 35(5):699-704. PubMed ID: 35942674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNAs in amyotrophic lateral sclerosis: from pathogenetic involvement to diagnostic biomarker and therapeutic agent development.
    Wang L; Zhang L
    Neurol Sci; 2020 Dec; 41(12):3569-3577. PubMed ID: 33006054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarkers in Human Peripheral Blood Mononuclear Cells: The State of the Art in Amyotrophic Lateral Sclerosis.
    Pansarasa O; Garofalo M; Scarian E; Dragoni F; Garau J; Di Gerlando R; Diamanti L; Bordoni M; Gagliardi S
    Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time for optimism in amyotrophic lateral sclerosis.
    Corcia P; Lunetta C; Vourc'h P; Pradat PF; Blasco H
    Eur J Neurol; 2023 May; 30(5):1459-1464. PubMed ID: 36773012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Biogenesis of miRNAs and Their Role in the Development of Amyotrophic Lateral Sclerosis.
    Liu J; Zhou F; Guan Y; Meng F; Zhao Z; Su Q; Bao W; Wang X; Zhao J; Huo Z; Zhang L; Zhou S; Chen Y; Wang X
    Cells; 2022 Feb; 11(3):. PubMed ID: 35159383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Advance in research on biomarkers for amyotrophic lateral sclerosis].
    Cheng Y; Chen Y; Shang H
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2021 Apr; 38(4):383-387. PubMed ID: 33834472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Potential Connection between Molecular Changes and Biomarkers Related to ALS and the Development and Regeneration of CNS.
    Glavač D; Mladinić M; Ban J; Mazzone GL; Sámano C; Tomljanović I; Jezernik G; Ravnik-Glavač M
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic and Prognostic Role of Blood and Cerebrospinal Fluid and Blood Neurofilaments in Amyotrophic Lateral Sclerosis: A Review of the Literature.
    Gagliardi D; Meneri M; Saccomanno D; Bresolin N; Comi GP; Corti S
    Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31450699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomarkers for amyotrophic lateral sclerosis.
    Bowser R; Cudkowicz M; Kaddurah-Daouk R
    Expert Rev Mol Diagn; 2006 May; 6(3):387-98. PubMed ID: 16706741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammatory checkpoints in amyotrophic lateral sclerosis: From biomarkers to therapeutic targets.
    Jiang Z; Wang Z; Wei X; Yu XF
    Front Immunol; 2022; 13():1059994. PubMed ID: 36618399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current State and Future Directions in the Diagnosis of Amyotrophic Lateral Sclerosis.
    Vidovic M; Müschen LH; Brakemeier S; Machetanz G; Naumann M; Castro-Gomez S
    Cells; 2023 Feb; 12(5):. PubMed ID: 36899872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multi-Omics for Biomarker Discovery and Target Validation in Biofluids for Amyotrophic Lateral Sclerosis Diagnosis.
    Mitropoulos K; Katsila T; Patrinos GP; Pampalakis G
    OMICS; 2018 Jan; 22(1):52-64. PubMed ID: 29356625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of miRNAs as Potential Biomarkers in Cerebrospinal Fluid from Amyotrophic Lateral Sclerosis Patients.
    Benigni M; Ricci C; Jones AR; Giannini F; Al-Chalabi A; Battistini S
    Neuromolecular Med; 2016 Dec; 18(4):551-560. PubMed ID: 27119371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New insights into the gene expression associated to amyotrophic lateral sclerosis.
    Recabarren-Leiva D; Alarcón M
    Life Sci; 2018 Jan; 193():110-123. PubMed ID: 29241710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrospinal fluid MFG-E8 as a promising biomarker of amyotrophic lateral sclerosis.
    Yang B; Wu Y; Wang Y; Yang H; Du B; Di W; Xu X; Shi X
    Neurol Sci; 2020 Oct; 41(10):2915-2920. PubMed ID: 32338335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New molecular diagnostic trends and biomarkers for amyotrophic lateral sclerosis.
    Pampalakis G; Mitropoulos K; Xiromerisiou G; Dardiotis E; Deretzi G; Anagnostouli M; Katsila T; Rentzos M; Patrinos GP
    Hum Mutat; 2019 Apr; 40(4):361-373. PubMed ID: 30556231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.